Expression of activation-induced cytidine deaminase (AID) in Burkitt lymphoma cells:: Rare AID-negative cell lines with the unmutated rearranged VH gene

被引:11
作者
Hardianti, MS
Tatsumi, E
Syampurnawati, M
Furuta, K
Saigo, K
Kawano, S
Kumagai, S
Nakamura, F
Matsuo, Y
机构
[1] Kobe Univ, Sch Med, Int Ctr Med Res, Dept Lab Med,Chuo Ku, Kobe, Hyogo 6500017, Japan
[2] Kobe Univ, Grad Sch Med, Int Ctr Med Res, Kobe, Hyogo, Japan
[3] Kobe Univ, Sch Med, Div Blood Transfus, Kobe, Hyogo, Japan
[4] Tenri Gen Hosp, Dept Hematol, Nara, Japan
[5] Hayashibara Biochem Res Inst, Fujisaki Cell Ctr, Okayama, Japan
关键词
activation-induced cytidine deaminase; somatic hypermutation; unmutated IgVH gene; Burkitt lymphoma;
D O I
10.1080/1042819031000139701
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Activation-induced cytidine deaminase (AID) is an enzyme that catalyzes somatic hypermutation (SHM) and class switch recombination (CSR) of the immunoglobulin (Ig) gene. The expression of AID was reported to be confined to the germinal center (GC). Burkitt lymphoma (BL) cells are regarded as being derived from GC cells. BL cells have been reported to have SHM in the Ig gene with variety in terms of degree, antigen selection and ongoing mutation characteristic. We investigated the expression of AID in 15 BL cell lines by RT-PCR. In only 2 BL cell lines, Tree92 and Black93, AID expression was not detected, and the IgV H gene of these 2 cell lines was not mutated. Tree92 expresses terminal deoxy-nucleotidyl transferase (TdT) and recombination activating gene (RAG)1, but Black93 does not, as is typical of the BL phenotype. BL cells are generally derived from GC B-cell expressing AID, but are rarely derived from the stage of B-lineage differentiation in which AID is not yet expressed, causing the absence of mutation in the IgV(H) .
引用
收藏
页码:155 / 160
页数:6
相关论文
共 25 条
[1]
Insight into Burkitt's lymphoma from immunoglobulin variable region gene analysis [J].
Chapman, CJ ;
Wright, D ;
Stevenson, FK .
LEUKEMIA & LYMPHOMA, 1998, 30 (3-4) :257-267
[2]
ANALYSIS OF V-H GENES USED BY NEOPLASTIC B-CELLS IN ENDEMIC BURKITTS-LYMPHOMA SHOWS SOMATIC HYPERMUTATION AND INTRACLONAL HETEROGENEITY [J].
CHAPMAN, CJ ;
MOCKRIDGE, CI ;
ROWE, M ;
RICKINSON, AB ;
STEVENSON, FK .
BLOOD, 1995, 85 (08) :2176-2181
[3]
V-R and V-L gene analysis in sporadic Burkitt's lymphoma shows somatic hypermutation, intraclonal heterogeneity, and a role for antigen selection [J].
Chapman, CJ ;
Zhou, JX ;
Gregory, C ;
Rickinson, AB ;
Stevenson, FK .
BLOOD, 1996, 88 (09) :3562-3568
[4]
VH gene analysis of Burkitt's lymphoma in children from north-western Iran [J].
Chapman, CJ ;
Wright, D ;
Feizi, HP ;
Davis, Z ;
Stevenson, FK .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (04) :1116-1123
[5]
Drexler HG, 2001, LEUKEMIA LYMPHOMA CE, DOI [10.1016/B978-012221970-2/50002-4, DOI 10.1016/B978-012221970-2/50002-4]
[6]
AID-dependent somatic hypermutation occurs as a DNA single-strand event in the BL2 cell line [J].
Faili, A ;
Aoufouchi, S ;
Guéranger, Q ;
Zober, C ;
Léon, A ;
Bertocci, B ;
Weill, JC ;
Reynaud, CA .
NATURE IMMUNOLOGY, 2002, 3 (09) :815-821
[7]
Frequent occurrence of deletions and duplications during somatic hypermutation:: Implications for oncogene translocations and heavy chain disease [J].
Goossens, T ;
Klein, U ;
Küppers, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (05) :2463-2468
[8]
FK506 inhibits anti-IgM antibody-induced apoptosis and 17kD endonuclease activity in the human B-cell line, MBC-1, established from Burkitt's lymphoma [J].
Higashigawa, M ;
Komada, Y ;
Shimono, Y ;
Nagata, T ;
Inamochi, H ;
Mao, XY ;
M'soka, T ;
Hori, H ;
Kawasaki, H ;
Sakurai, M .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (04) :908-913
[9]
EVOLUTIONARY NUCLEOTIDE REPLACEMENTS IN DNA [J].
JUKES, TH ;
KING, JL .
NATURE, 1979, 281 (5732) :605-606
[10]
Linking class-switch recombination with somatic hypermutation [J].
Kinoshita, K ;
Honjo, T .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (07) :493-503